AI-generated summary
The authors ran a single-blind controlled trial of 660 nm red light therapy in 30 patients with burning mouth syndrome, comparing active treatment with a sham control over 10 weekly sessions. They report no statistically significant difference in pain reduction between the groups, though both groups showed a significant drop in maximum pain compared with baseline. The authors call for larger randomized trials with longer follow-up.
- Participants
- 30
- Who or what was studied
- Patients diagnosed with burning mouth syndrome
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a small sample, a quasi-experimental design, and a possible sham placebo effect that the authors say needs further study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 100 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Sham, Placebo effect, Power output, Sample size, Wavelength, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.